Spineway SA (EPA:ALSPW)
France · Delayed Price · Currency is EUR 0.1272
-0.0038 (-2.90%)
Sep 5, 2025, 5:35 PM CET
Spineway Revenue
Spineway had revenue of 5.73M EUR in the half year ending June 30, 2025, a decrease of -4.97%. This brings the company's revenue in the last twelve months to 11.80M, down -1.58% year-over-year. In the year 2024, Spineway had annual revenue of 12.73M with 12.11% growth.
Revenue (ttm)
11.80M
Revenue Growth
-1.58%
P/S Ratio
0.21
Revenue / Employee
274.44K
Employees
49
Market Cap
2.53M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 12.73M | 1.38M | 12.11% |
| Dec 31, 2023 | 11.36M | 2.71M | 31.34% |
| Dec 31, 2022 | 8.65M | 3.61M | 71.76% |
| Dec 31, 2021 | 5.04M | 523.00K | 11.59% |
| Dec 31, 2020 | 4.51M | -1.07M | -19.23% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| EssilorLuxottica Société anonyme | 27.24B |
| Sanofi | 45.74B |
| Sartorius Stedim Biotech | 2.90B |
| bioMérieux | 4.12B |
| Eurofins Scientific SE | 7.14B |
| Ipsen | 3.76B |
| ABIVAX Société Anonyme | 10.59M |
| Virbac | 1.40B |